BROKERS CHOICE: MANAPPURAM, MUTHUTFIN, KIMS, VBL, NYKAA, SWIGGY, PAYTM, YESBANK, BHARTIAIRTEL, IREDA, RVNL
AHMEDABAD, 11 FEBRUARY
CLSA on Muthoot Fin: Upgrade to Outperform on Company, raise target price at Rs 2400 (Positive)
CLSA on Manappuram: Maintain Buy on Company, raise target price at Rs 225 (Positive)
HSBC on Sobha: Maintain Buy on Company, raise target price at Rs 1900 (Positive)
HSBC on KIMS: Maintain Buy on Company, target price at Rs 725 (Positive)

MS on VBL: Maintain Overweight on Company, target price at Rs 674 (Positive)
MS on Oil India: Maintain Overweight on Company, target price at Rs 625 (Positive)
MS on Nykaa: Maintain Overweight on Company, target price at Rs 200 (Positive)
HSBC on M&M: Maintain Buy on Company, raise target price at Rs 3520 (Positive)
HSBC on Rainbow: Maintain Buy on Company, target price at Rs 1720 (Positive)
MS on Apollo Hospitals: Maintain Overweight on Company, target price at Rs 8159 (Positive)
Macquarie on Bharti Airtel: Maintain Neutral on Company, target price at Rs 1710 (Positive)
Citi on Swiggy: Initiate Buy on Company, target price at Rs 480 (Positive)
Morgan Stanley on Bajaj Finance: Fits the quality large cap thematic, has a tested model and good vintage (Positive)

Macquarie on Pharma: Believe Q4 expectations for pharma companies is derisked. IPCA, Sun Pharma, Zydus Life and Dr Reddy outperformed (Positive)
UBS on M&M: Maintain Neutral on Company, target price at Rs 3460 (Neutral)
Investec on Alkem: Maintain Sell on Company, cut target price at Rs 5250 (Neutral)
GS on Eicher Motors: Maintain Buy on Company, cut target price at Rs 6000 (Neutral)
CLSA on Hindalco: Maintain Outperform on Company, target price at Rs 800 (Neutral)
Jefferies on Hindalco: Maintain Buy on Company, target price at Rs 800 (Neutral)
Citi on Hindalco: Maintain Buy on Company, target price at Rs 725 (Neutral)
UBS on M&M: Maintain Neutral on Company, target price at Rs 3460 (Neutral)
Nomura on Anant Raj: Initiate Neutral on Company, target price at Rs 750 (Neutral)
Jefferies on Grasim: Maintain Buy on Company, target price at Rs 3125 (Neutral)
MS on Grasim: Maintain Equal weight on Company, target price at Rs 2950 (Neutral)
HSBC on OLA Elec: Maintain Hold on Company, target price at Rs 70 (Neutral)
HSBC on Alkem: Maintain Hold on Company, target price at Rs 5395 (Neutral)
MS on Crompton: Maintain Underweight on Company, target price at Rs 402 (Neutral)
HSBC on Delhivery: Maintain Buy on Company, cut target price at Rs 400 (Neutral)
MS on Eicher Motors: Maintain Underweight on Company, cut target price at Rs 3855 (Negative)
UBS on Eicher Motors: Downgrade to Neutral on Company, cut target price at Rs 5650 (Negative)
(Disclaimer: The information provided here is investment advice only. Investing in the markets is subject to risks and please consult your advisor before investing.)
(સ્પષ્ટતા: અત્રેથી આપવામાં આવતી તમામ પ્રકારની માહિતી કોઇપણ પ્રકારે રોકાણ/ ટ્રેડીંગ માટેની સલાહ નથી. બજારોમાં રોકાણ જોખમોને આધીન છે અને રોકાણ કરતા પહેલા કૃપા કરીને તમારા સલાહકારની સલાહ લો.)